(Q44825076)

English

Clinical trials update from the American Heart Association meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT.

scientific article published in April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Clinical trials update from the American Heart Association meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Pierpaolo Pellicori

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Nick Freemantle

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Alison P Coletta

2

object named as

Alison P Coletta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Laszlo Buga

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Renjith Antony

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Andrew L Clark

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

460-465

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Eplerenone in patients with systolic heart failure and mild symptoms

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Effect of eplerenone versus spironolactone on cortisol and hemoglobin A₁(c) levels in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Cardiac-resynchronization therapy for the prevention of heart-failure events.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Cardiac-resynchronization therapy for mild-to-moderate heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction -- a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Structured telephone support or telemonitoring programs for patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Telemonitoring in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

State of the art: using natriuretic peptide levels in clinical practice

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

2010 Focused Update of ESC Guidelines on device therapy in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR015

21 January 2018

Identifiers

10.1093/EURJHF/HFR015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21436363%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44825076&oldid=2185911084"